![Regencell Bioscience Holdings Limited logo](/logos/RGC.webp)
Regencell Bioscience Holdings Limited
NASDAQ:RGC
Overview | Financials
Company Name | Regencell Bioscience Holdings Limited |
Symbol | RGC |
Currency | USD |
Price | 6.69 |
Market Cap | 87,056,301 |
Dividend Yield | 0% |
52-week-range | 3.03 - 32.44 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Yat-Gai Au |
Website | https://www.regencellbioscience.com |
An error occurred while fetching data.
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD